drugset / Trial / NCT00940381
Sirolimus and Cetuximab in Advanced Malignancies
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find the highest tolerable dose of the combination of sirolimus and cetuximab that can be given to patients with advanced cancer. The safety of this drug combination will also be studied.
Timeline
- Start
- 2009-07
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | 65 mg/m2 | Intravenous |
| Subject | Sirolimus | Small molecule | 1 mg | Oral |